S 111 (Uribel hyoscyamine 0.12 mg / methenamine 118 mg/methylene blue 10 mg / phenyl salicylate 36 mg / sodium phosphate 40.8 mg)

Generic Name: hyoscyamine/methenamine/methylene blue/phenyl salicylate

Pill with imprint S 111 is Purple, Capsule-shape and has been identified as Uribel hyoscyamine 0.12 mg / methenamine 118 mg/methylene blue 10 mg / phenyl salicylate 36 mg / sodium phosphate 40.8 mg. It is supplied by Mission Pharmacal Company.

Uribel is used in the treatment of urinary tract infection and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Uribel hyoscyamine 0.12 mg / methenamine 118 mg/methylene blue 10 mg / phenyl salicylate 36 mg / sodium phosphate 40.8 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for S 111

Uribel hyoscyamine 0.12 mg / methenamine 118 mg/methylene blue 10 mg / phenyl salicylate 36 mg / sodium phosphate 40.8 mg S 111

Uribel

Generic Name: hyoscyamine/methenamine/methylene blue/phenyl salicylate
Imprint: S 111
Strength: hyoscyamine 0.12 mg / methenamine 118 mg/methylene blue 10 mg / phenyl salicylate 36 mg / sodium phosphate 40.8 mg
Color: Purple
Size: 19.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Urinary antispasmodics
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: Mission Pharmacal Company
National Drug Code (NDC): 00076-0111
Inactive Ingredients: calcium phosphate dibasic anhydrous, gelatin, magnesium stearate, propylene glycol, shellac, silicon dioxide
Note: Inactive ingredients may vary.